ACTINIUM PHARMACEUTICALS, INC. Deferred Tax Assets, Tax Deferred Expense, Other
ACTINIUM PHARMACEUTICALS, INC. (ATNM) had Deferred Tax Assets, Tax Deferred Expense, Other of -$1.42 million as of 2013-12-31, per its 10-K filed 2014-02-28.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther · last filed 2014-02-28
- 2013-12-31: Deferred Tax Assets, Tax Deferred Expense, Other -$1.42M.
- 2012-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $233.04K.
- 2011-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $4.75K.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Other |
|---|---|
| 2013-12-31 | -$1.42M 10-K · filed 2014-02-28 |
| 2012-12-31 | $233.04K 10-K · filed 2014-02-28 |
| 2011-12-31 | $4.75K 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |